Keryx Biopharmaceuticals, Inc.
(NASDAQ : KERX)

( )
KERX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.09%165.320.7%$1060.19m
PFEPfizer Inc. 3.69%50.070.9%$942.34m
ABBVAbbVie, Inc. 0.35%142.571.9%$843.43m
MRKMerck & Co., Inc. 2.33%91.010.7%$812.67m
LLYEli Lilly & Co. 2.53%307.781.1%$790.95m
BMYBristol-Myers Squibb Co. 1.48%75.561.0%$658.77m
SIGASIGA Technologies, Inc. -0.16%24.750.0%$468.87m
AZNAstraZeneca Plc 3.08%66.641.0%$384.79m
GBTGlobal Blood Therapeutics, Inc. 0.27%66.755.6%$307.02m
ALNYAlnylam Pharmaceuticals, Inc. 1.94%233.858.2%$285.78m
GSKGSK Plc 0.84%36.030.3%$273.25m
HZNPHorizon Therapeutics Plc 0.55%67.475.4%$217.29m
KRTXKaruna Therapeutics, Inc. 6.17%277.420.0%$207.23m
CCXIChemoCentryx, Inc. 0.24%50.722.9%$191.50m
NVONovo Nordisk A/S -0.67%107.480.1%$184.93m

Company Profile

Keryx Biopharmaceuticals is a biopharmaceutical company that is focused on the development and commercialization of medicines for chronic kidney diseases. Keryx Biopharmaceuticals offers Auryxia, a medicine that is able to lower the amount of phosphate in blood. It supports investigator sponsored research conducted by independent researchers with Auryxia. It facilitates programs such as Reimbursement Help, Copay Program, and Patient Assistance. Keryx Biopharmaceuticals was founded in October 1998 and is based in New York.